BRCA1 and breast carcinoma: Breast cancer studies by Pawitan and Bild demonstrated that CXCL1 expression had a significant increase in the BRCA1 mutant (P = 0.0035) and triple-negative (P = 0.0005) breast cancer patients, respectively20,21 (Fig. 7e).